- NSE
- STAR
- BSE
- 532531
- ISIN
- INE939A01011
STRIDES PHARMA SCI
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,002.20
+₹2.60 (+0.26%)
NSE close ·
STRIDES PHARMA SCI closed at ₹1,002.20 on 9 Nov 2026, up 0.26% on the day, and is up 5.70% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹793.55 to ₹1,235.10.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹9,238 Cr
- P/E (TTM)
- 15.0
- Industry P/E
- 35.5
- EPS (TTM)
- ₹66.90
- P/B
- 2.70
- Book value
- ₹370.66
- ROE
- 18.1%
- ROCE
- 17.4%
- Debt/equity
- 0.54
- Operating margin
- 15.2%
- Net margin
- 11.8%
- Dividend yield
- 0.50%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +12.65% | +11.23% |
| Net profit | +54.32% | — |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹1,434 Cr | ₹134 Cr | +1.97% | ₹14.19 |
| Jun 2026 | ₹1,270 Cr | ₹165 Cr | +56.73% | ₹17.02 |
| Mar 2026 | ₹1,332 Cr | ₹129 Cr | +51.00% | ₹13.77 |
| Dec 2025 | ₹1,302 Cr | ₹208 Cr | +131.14% | ₹21.92 |
| Sep 2025 | ₹1,248 Cr | ₹132 Cr | +40.43% | ₹13.84 |
| Jun 2025 | ₹1,128 Cr | ₹106 Cr | +54.57% | ₹10.81 |
| Mar 2025 | ₹1,202 Cr | ₹85.62 Cr | +719.86% | ₹8.92 |
| Dec 2024 | ₹1,159 Cr | ₹90.04 Cr | +66.56% | ₹9.55 |
Armor risk check
STRIDES PHARMA SCI moves about 2× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is STRIDES PHARMA SCI's share price today?
STRIDES PHARMA SCI (NSE: STAR) closed at ₹1,002.20 on 9 Nov 2026, up 0.26% from the previous close of ₹999.60. It traded between ₹1,000.00 and ₹1,039.90 that day.
What are STRIDES PHARMA SCI's 52-week high and low?
Over the last 52 weeks STRIDES PHARMA SCI traded between ₹768.65 and ₹1,260.90, adjusted for splits and bonuses.
What are STRIDES PHARMA SCI's NSE symbol, BSE code and ISIN?
STRIDES PHARMA SCI has NSE symbol STAR, BSE code 532531, ISIN INE939A01011.
How has STRIDES PHARMA SCI performed over 1, 3 and 5 years?
STRIDES PHARMA SCI's share price return: 1Y +5.70%, 3Y +27.63% a year, 5Y +12.71% a year. Dividends are not included.
Does STRIDES PHARMA SCI pay a dividend?
Yes. STRIDES PHARMA SCI's latest dividend went ex on 31 Jul 2026: Final · ₹5.00 per share. Dividends over the past year come to a yield of 0.50% at the latest close.
What is STRIDES PHARMA SCI's P/E ratio?
STRIDES PHARMA SCI's P/E ratio is 15.0: the ₹1,002.20 close on 9 Nov 2026 over trailing twelve-month EPS of ₹66.90 (consolidated, four quarters to 30 Sep 2026).
What is STRIDES PHARMA SCI's market cap?
STRIDES PHARMA SCI's market cap is ₹9,238 Cr at the close on 9 Nov 2026.
Which sector is STRIDES PHARMA SCI in?
STRIDES PHARMA SCI is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how STRIDES PHARMA SCI fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app